Training the Next Generation of MRD Experts
MIRACLE offers a unique, structured training programme designed to equip a new generation of researchers with the expertise needed to tackle minimal residual disease (MRD) in leukemia. Rooted in the principles of the Marie Skłodowska-Curie Actions, MIRACLE combines interdisciplinary scientific excellence with an intersectoral training environment that spans academia, clinical institutions, and industry. Each of the ten Doctoral Candidates (DCs) will engage in an integrated research project while receiving specialised training in cutting-edge technologies, including single-cell multi-omics, advanced bioinformatics, organ-on-chip systems, and immunotherapy development.
Through international secondments, participation in network-wide training events, and personalised career development plans, the researchers will develop a unique skill set that bridges fundamental science and clinical application. MIRACLE’s comprehensive approach aims not only to advance leukemia treatment but also to prepare its researchers for diverse career paths in science, innovation, and beyond.
MIRACLE Winter Academy 1 (SS1)
19 – 23 January 2026
Amsterdam UMC, NL
Setting the Stage for a New Generation of MRD Experts
The MIRACLE Winter Academy 1 launches our innovative doctoral training. Bringing together all MIRACLE DCs for the first time. The programme is enriched by keynote lectures and sessions from internationally recognized experts whose insights are critical not only for training the next generation of researchers but also for shaping the broader field of leukemia research and treatment.
Lectures and discussions will highlight state-of-the-art MRD detection, therapeutic innovation, and emerging technologies, addressing topics of high relevance for both academic and clinical audiences. In addition to scientific training, each DC will benefit from a dedicated personal development programme, including professional skills workshops and individual coaching sessions.